In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions

Infection and Immunity

Volumn 70, Issue 11, 2002, Pages 6330-6338

  Fenhalls, Gael ^a   Stevens, Liesel ^a   Moses, Lorraine ^a   Bezuidenhout, Juanita ^a   Betts, Joanna C ^a   Van Helden, Paul ^a   Lukey, Pauline T ^a   Duncan, Ken ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; GENE PRODUCT; ISONIAZID; PROTEIN ICL; PROTEIN NARX; PROTEIN RV2557; PROTEIN RV2558; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA PROBE; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; IN VITRO STUDY; LUNG GRANULOMA; LUNG PARENCHYMA; LUNG TUBERCULOSIS; LYMPHOCYTE; MACROPHAGE; MALE; MICROENVIRONMENT; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; PERSISTENT INFECTION; PRIORITY JOURNAL; RNA RNA HYBRIDIZATION; SEQUENCE HOMOLOGY;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; FEMALE; GENE EXPRESSION PROFILING; GRANULOMA, RESPIRATORY TRACT; HUMANS; IN SITU HYBRIDIZATION; MALE; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; RNA, MESSENGER; TUBERCULOSIS, PULMONARY;

EID: 0036839650     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.11.6330-6338.2002     Document Type: Article

References (36)

1. Alland, D., 1. Kramnik, T. R. Weisbrod, L. Otsubo, R. Cerny, L. P. Miller, W. R. Jacobs, Jr., and B. R. Bloom. 1998. Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95:13227-13232.
2. Alland, D., A. J. Steyn, T. Weisbrod, K. Aldrich, and W. R. Jacobs, Jr. 2000. Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition, J. Bacteriol. 182:1802-1811.
3. Betts, J. C., P. T. Lukey, L. C. Robb, R. A. McAdam, and K. Duncan. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43:717-731.
4. Dannenberg, A. M., and G. A. Rook. 1994, Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses-dual mechanisms that control bacillary multiplication, p. 459-483. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection and control. American Society for Microbiology, Washington, D.C.
5. Desjardin, L. E., M. D. Perkins, K. Wolski, S. Haun, L. Teixeira, Y. Chen, J. L. Johnson, J. J. Ellner, R. Dietze, J. Bates, M. D. Cave, and K. D. Eisenach. 1999. Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. Am. J. Respir. Crit. Care Med. 160:203-210.
6. Fairbairn, I. P., C. B. Stober, D. S. Kumararatne, and D. A. Lammas. 2001. ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. J. Immunol. 167:3300-3307.
7. Fayyazi, A., B. Eichmeyer, A. Soruri, S. Schweyer, J. Herms, P. Schwarz, and H. J. Radzun. 2000. Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis. J. Pathol. 191:417-425.
8. Fenhalls, G., L. Stevens-Muller, R. Warren, N. Carroll, J. Bezuidenhout, P. van Helden, and P. Bardin. 2002. Localisation of mycobacterial DNA and mRNA in human tuberculous granulomas. J. Microbiol. Methods 51:197-208.
9. Fenhalls, G., L. Stevens, J. Bezuidenhout, G. E. Amphlett, K. Duncan, P. Bardin, and P. T. Lukey. 2002. Distribution of IFN-γ. IL-4 and TNF-α protein and CD8 T cells producing IL-12p40 mRNA in human lung tuber. culous granulomas. Immunology 105:325-335.
10. Fenhalls, G., A. Wong, J. Bezuidenhout, P. van Helden, P. Bardin, and P. T. Lukey. 2000. In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas. Infect. Immun. 68:2827-2836.
11. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.
12. Gillespie, J., L. L. Barton, and E. W. Rypka. 1986. Phenotypic changes in mycobacteria grown in oxygen-limited conditions. J. Med. Microbiol. 21:251-255.
13. Graham, J. E., and J. E. Clark-Curtiss. 1999. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc. Natl. Acad. Sci. USA 96:11554-11559.
14. Hellyer, T. J., L. E. Desjardin, L. Teixeira, M. D. Perkins, M. D. Cave, and K. D. Eisenach. 1999. Detection of viable Mycobacterium tuberculosis by reverse transcriptase-strand displacement amplification of mRNA J. Clin. Microbiol. 37:518-523.
15. Höner Zu Bentrup, K., A. Miczak, D. L. Swenson, and D. G. Russell. 1999. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Myvcobacterium tuberculosis. J. Bacteriol. 181:7161-7167.
16. Höner Zu Bentrup, K., and D. G. Russell. 2001. Mycobacterial persistence: adaptation to a changing environment. Trends Microbiol. 9:597-605.
17. Hu, Y. M., P. D. Butcher, K. Sole, D. A. Mitchison, and A. R. Coates. 1998. Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock. FEMS Microbiol. Lett. 158:139-145.
18. Hulten, K., H. M. El Zimaity, T. J. Karttunen, A. Almashhrawi, M. R. Schwartz, D. Y. Graham, and F. A. El Zaatari. 2001. Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization. Am. J. Gastroenterol. 96:1529-1535.
19. Humphrey, D. M., and M. H. Weiner. 1987. Mycobacterial antigen detection by immunohistochemistry in pulmonary tuberculosis. Hum. Pathol. 18:701-708.
20. Hutter, B., and T. Dick. 1999. Upregulation of narX, encoding a putative fused nitrate reductase' in anaerobic dormant Mycobacterium bovis BCG. FEMS Microbiol. Lett. 178:63-69.
21. Keane, J., S. Gershon, R. Wise, E. Mirabile-Levens, J. Kasznica, W. D. Schwieterman, J. N. Siegel, and M. M. Braun. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor alpha neutralizing agent. New Engl. J. Med. 345:1098-1104.
22. Kusner, D. J., and J. A. Barton. 2001. ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion. J. Immunol. 167:3308-3315.
23. McKinney, J. D., K. Höner Zu Bentrup, E. J. Munoz-Elias, A. Miczak, B. Chen, W. T. Chan, D. Swenson, J. C. Sacchettini, W. R. Jacobs, Jr., and D. G. Russell. 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735-738.
24. Parrish, N. M., J. D. Dick, and W. R. Bishal. 1998. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 6:107-112.
25. Patel, B. K., D. K. Banerjee, and P. D. Butcher. 1993. Determination of Mycobacterium leprae viability by polymerase chain reaction amplification of 71-kDa heat-shock protein mRNA. J. Infect. Dis. 168:799-800.
26. Raupach, B., and S. H. E. Kaufmann. 2001. Immune responses to intracellular bacteria. Curr. Opin. Immunol. 13:417-428.
27. Roach, D. R., A. G. Bean, C. Demangel, M. P. France, H. Briscoe, and W. J. Britton. 2002. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168:4620-4627.
28. Roth, S., E. Delmont, P. Heudier, R. Kaphan, E. Cua, J. Castela, J. M. Verdier, R. M. Chichmanian, and J. G. Fuzibet. 2002. Anti-TNF alpha monoclonal antibodies (Infliximab) and tuberculosis: apropos of 3 cases. Rev. Med. Interne 23:312-316.
29. Sherman, D. R., M. Voskuil, D. Schnappinger, R. Liao, M. I. Harrell, and G. K. Schoolnik. 2001. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc. Natl. Acad. Sci. USA 98:7534-7539.
30. Slayden, R. A., and C. E. Barry III. 2000. The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect. 2:659-669.
31. Stenger, S., D. A. Hanson, R. Teitelbaum, P. Dewan, K. R. Niazi, C. J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melian, C. Bogdan, S. A. Porcelli, B. R. Bloom, A. M. Krensky, and R. L. Modlin. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121-125.
32. Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun. 64:2062-2069.
33. Wayne, L. G., and L. G. Hayes. 1998. Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis. Tuberc. Lung Dis. 79:127-132.
34. Wayne, L. G., and K. Y. Lin. 1982. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect. Immun. 37:1042-1049.
35. Wayne, L. G., and C. D. Sohaskey. 2001. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55:139-163.
36. Wilson, M., J. DeRisi, H. H. Kristensen, P. Imboden, S. Rane, P. O. Brown, and G. K. Schoolnik. 1999. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc. Natl. Acad. Sci. USA 96:12833-12838.